Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Geyer

Showing results (51-60 of 112) with videos related to

Pageof 12
Sort By:
Diabetes Care|July 30, 2021
<i>TCF7L2</i> Genetic Variants Do Not Influence Insulin Sensitivity or Secretion Indices in Autoantibody-Positive Individuals at Risk for Type 1 DiabetesMaria J Redondo, Megan V Warnock, Ingrid M Libman, et al.
Insights Into Imaging|February 9, 2026
Precision imaging and evolving therapies in paragangliomas and pheochromocytomas: from molecular diagnostics to imaging-guided managementAurelie Choucair, Anna Zdunek, Matthew Liao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2005
Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non-Hodgkin's lymphoma: a phase II trial in the North Central Cancer Treatment GroupThomas E Witzig, Allen M Vukov, Thomas M Habermann, et al.
Shock (Augusta, Ga.)|July 1, 2014
Innate immune function predicts the development of nosocomial infection in critically injured childrenJennifer A Muszynski, Ryan Nofziger, Kristin Greathouse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2012
Impact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of sequential cancer and leukemia group B studiesJennifer A Woyach, Amy S Ruppert, Kanti Rai, et al.
JACC. Advances|January 20, 2026
Spinal Stenosis and Carpal Tunnel Syndrome as Surrogates of Transthyretin Amyloid CardiomyopathyLaura De Michieli, Susan Geyer, Ellen McPhail, et al.
Diabetologia|November 27, 2019
The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screeningLaura M Jacobsen, Laura Bocchino, Carmella Evans-Molina, et al.
Endocrine-Related Cancer|January 12, 2026
Cabozantinib for Advanced Grade 3 Neuroendocrine Tumors: Subgroup Analysis of the Phase 3 CABINET Trial (Alliance A021602)Jonathan R Strosberg, Tyler Zemla, Susan Geyer, et al.
Leukemia & Lymphoma|December 22, 2012
Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemiaAlison R Walker, Rebecca Klisovic, Jeffrey S Johnston, et al.
Cancer Investigation|June 17, 2006
A Phase II NCCTG study of irinotecan and docetaxel in previously treated patients with non-small cell lung cancerJulian R Molina, Daniel Nikcevich, Shauna Hillman, et al.
Pageof 12

Showing results (51-60 of 112) with videos related to

Sort By:
Pageof 12
Diabetes Care|July 30, 2021
<i>TCF7L2</i> Genetic Variants Do Not Influence Insulin Sensitivity or Secretion Indices in Autoantibody-Positive Individuals at Risk for Type 1 DiabetesMaria J Redondo, Megan V Warnock, Ingrid M Libman, et al.
Insights Into Imaging|February 9, 2026
Precision imaging and evolving therapies in paragangliomas and pheochromocytomas: from molecular diagnostics to imaging-guided managementAurelie Choucair, Anna Zdunek, Matthew Liao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2005
Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non-Hodgkin's lymphoma: a phase II trial in the North Central Cancer Treatment GroupThomas E Witzig, Allen M Vukov, Thomas M Habermann, et al.
Shock (Augusta, Ga.)|July 1, 2014
Innate immune function predicts the development of nosocomial infection in critically injured childrenJennifer A Muszynski, Ryan Nofziger, Kristin Greathouse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2012
Impact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of sequential cancer and leukemia group B studiesJennifer A Woyach, Amy S Ruppert, Kanti Rai, et al.
JACC. Advances|January 20, 2026
Spinal Stenosis and Carpal Tunnel Syndrome as Surrogates of Transthyretin Amyloid CardiomyopathyLaura De Michieli, Susan Geyer, Ellen McPhail, et al.
Diabetologia|November 27, 2019
The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screeningLaura M Jacobsen, Laura Bocchino, Carmella Evans-Molina, et al.
Endocrine-Related Cancer|January 12, 2026
Cabozantinib for Advanced Grade 3 Neuroendocrine Tumors: Subgroup Analysis of the Phase 3 CABINET Trial (Alliance A021602)Jonathan R Strosberg, Tyler Zemla, Susan Geyer, et al.
Leukemia & Lymphoma|December 22, 2012
Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemiaAlison R Walker, Rebecca Klisovic, Jeffrey S Johnston, et al.
Cancer Investigation|June 17, 2006
A Phase II NCCTG study of irinotecan and docetaxel in previously treated patients with non-small cell lung cancerJulian R Molina, Daniel Nikcevich, Shauna Hillman, et al.
Pageof 12